Status:
RECRUITING
Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens
Lead Sponsor:
CHU de Reims
Conditions:
Ventilator Associated Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Ventilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation. Today, bronchoalveo...
Detailed Description
Ventilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation. Today, bronchoalveo...
Eligibility Criteria
Inclusion
- inclusion criteria :
- Adult patients, hospitalized in intensive care unit
- on mechanical ventilation for at least 48 hours
- Suspected VAP
- With an indication for bronchoalveolar lavage (BAL)
- exclusion criteria :
- Patients under legal protection or without social security coverage
- Pregnant women
- Previous episode of VAP during the same hospitalization
Exclusion
Key Trial Info
Start Date :
March 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 6 2026
Estimated Enrollment :
265 Patients enrolled
Trial Details
Trial ID
NCT06554327
Start Date
March 6 2025
End Date
October 6 2026
Last Update
June 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France